Pharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends
作者： Jutta M. Stoffers , Klaus Lieb
DOI: 10.1007/S11920-014-0534-0
关键词: Psychiatry 、 Clinical trial 、 Beneficial effects 、 Clinical psychology 、 Mood stabilisers 、 Medical treatment 、 Borderline personality disorder 、 Pharmacotherapy 、 Drug treatment 、 Psychology 、 MEDLINE
摘要: Drug treatment of patients with borderline personality disorder (BPD) is common but mostly not supported by evidence from high-quality research. This review summarises the current …
springer.com
sci-hub.se 参考文章(93)
Néstor Szerman, Manuel Ruíz, Lola Peris, [Efficacy and safety of gabapentin in Borderline Personality Disorder: a six-month, open-label study]. Vertex (Buenos Aires, Argentina). ,vol. 18, pp. 418- 422 ,(2007)
Silvio Bellino, Camilla Rinaldi, Filippo Bogetto, Adaptation of Interpersonal Psychotherapy to Borderline Personality Disorder: A Comparison of Combined Therapy and Single Pharmacotherapy: The Canadian Journal of Psychiatry. ,vol. 55, pp. 74- 81 ,(2010) , 10.1177/070674371005500203
Ann Romine, S. Charles Schulz, Michael Miller, Susanne S Lee, Adit Adityanjee, Mary Freitag, Sue Song, Richelle Moen, Efficacy of extended-release divalproex combined with "condensed" dialectical behavior therapy for individuals with borderline personality disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. ,vol. 24, pp. 255- 260 ,(2012)
G Paul Amminger, Andrew M Chanen, Susanne Ohmann, Claudia M Klier, Nilufar Mossaheb, Andreas Bechdolf, Barnaby Nelson, Andrew Thompson, Patrick D McGorry, Alison R Yung, Miriam R Schäfer, Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, Randomized Controlled Trial: The Canadian Journal of Psychiatry. ,vol. 58, pp. 402- 408 ,(2013) , 10.1177/070674371305800705
Jutta M Stoffers, Michael Ferriter, Birgit A Völlm, Simon Gibbon, Hannah Jones, Conor Duggan, Neele Reiss, Klaus Lieb, Psychological interventions for people with histrionic personality disorder The Cochrane Library. ,(2012) , 10.1002/14651858.CD009668
Fluoxetine in the treatment of borderline and schizotypal personality disorders. American Journal of Psychiatry. ,vol. 148, pp. 1064- 1067 ,(1991) , 10.1176/AJP.148.8.1064
Paul J. Markovitz, Susan C. Wagner, Venlafaxine in the treatment of borderline personality disorder. Psychopharmacology Bulletin. ,vol. 31, pp. 773- 777 ,(1995)
Jutta Stoffers, Birgit A Völlm, Gerta Rücker, Antje Timmer, Nick Huband, Klaus Lieb, None, Pharmacological interventions for borderline personality disorder Cochrane Database of Systematic Reviews. ,(2010) , 10.1002/14651858.CD005653.PUB2
JoséManuel De la Fuente, Françoise Lotstra, A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacology. ,vol. 4, pp. 479- 486 ,(1994) , 10.1016/0924-977X(94)90296-8
Alan Schatzberg, John Looper, Rebecca Henke, Mark Albanese, Jane Schwartz, Edison Miyawaki, Carl Salzman, Abbie N. Wolfson, Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology. ,vol. 15, pp. 23- 29 ,(1995) , 10.1097/00004714-199502000-00005